Few previous studies in Western populations have reported an association between C-reactive protein (CRP) and prehypertension. However, no previous study has examined this association in Asians. We examined individuals who were free of hypertension from two independent population-based studies in Singapore: the Singapore Prospective Study Programme (SP2, n ¼ 2843 Chinese, Malay and Indians aged X24 years) and the Singapore Malay Eye Study (SiMES, n ¼ 957 Malays, aged 40 --80 years). Prehypertension was defined as systolic blood pressure (BP) 120 --139 mm Hg or diastolic BP 80 --89 mm Hg. CRP was analyzed as categories (o1, 1 --3, 43 mg l À1 ). The prevalence of prehypertension increased with increasing categories of CRP in both cohorts (P for trend o0.05 in both cohorts). After adjusting for potential confounders including body mass index (BMI), smoking and diabetes, persons with higher levels of CRP were more likely to have prehypertension in both SP2 (compared with CRP o1 mg l
INTRODUCTION
Hypertension is an established risk factor for cardiovascular disease (CVD). 1 Experimental evidences suggest that inflammation has an important role in the initiation and development of hypertension in animal 2, 3 and human studies. 4 ,5 C-reactive protein (CRP), the most extensively studied inflammatory marker in clinical studies, has been identified as a risk factor for cardiovascular morbidity 6 and mortality. 7 Several cross-sectional, 8, 9 prospective 10, 11 and case--control studies 12 have also documented an independent association between CRP and hypertension in different populations.
Prehypertension is an earlier stage in the continuum of hypertension where prevention efforts have been shown to be effective in delaying or preventing the onset of hypertension. 13 Prospective studies have shown that prehypertension is associated with a twofold higher risk of CVD 14 and subsequent conversion to hypertension. 15 Clinical trials have shown that lifestyle 16 or therapeutic interventions at the prehypertension stage effectively reduce the excess risk of hypertension 17, 18 or CVD. 19 Few studies conducted among Western populations have shown a positive association between high CRP levels and prehypertension. 10, 20, 21 The prevalence of prehypertension is on the rise among Asian populations and studies have shown that nearly one in three Asian adults have blood pressure (BP) in the range of prehypertension. 22 --24 However, to our knowledge no previous study has examined the association between CRP and prehypertension among Asian subjects without hypertension. In this context, we examined the association between CRP levels and prehypertension in a multi-ethnic Asian population of Chinese, Malay and Indian participants from two population-based cohorts in Singapore.
METHODS
The data for this study are derived from two independent populationbased studies, the Singapore Prospective Study Programme (SP2) and the Singapore Malay Eye Study (SiMES) in Singapore. Details of the population selection and study methods have been published previously. 25, 26 SP2 is a population-based cross-sectional study of participants aged X24 years (age range in the current study ¼ 24 --79 years) living in Singapore. Of the 7742 eligible participants, 5157 attended the health examination. Of the 4831 participants with CRP and BP measurements, after excluding those with hypertension (n ¼ 1979), ethnic groups other than Chinese, Malay and Indians (n ¼ 2), those with missing information on variables included in the multivariable model, including education, smoking, drinking status, systolic and diastolic (BP) and total cholesterol (n ¼ 6), and those with CRP levels 4100 mg l À1 (n ¼ 1), 2843 were included in the final analysis.
SiMES is a population-based cross sectional study of Malay adults aged 40 --80 years living in Singapore. 26 Of the 3106 participants with CRP and BP measurements, after excluding those with hypertension (n ¼ 2131), those with missing information on variables included in the multivariable model (n ¼ 17) and those with CRP levels 4100 mg l À1 (n ¼ 1), 957 were included in the final analysis.
Participants from both SP2 and SiMES cohorts were examined in the same study clinic (Singapore Eye Research Institute). Questionnaire and clinic examinations were similar in both studies, except that blood samples were collected in non-fasting state in SiMES and in fasting state in SP2. Informed consent was obtained from all study participants and ethics approval was obtained from the institutional review boards of National University of Singapore and Singapore General Hospital for SP2 and from the institutional review board of Singapore Eye Research Institute for SiMES.
Main outcome of interest: prehypertension BP measurements were taken twice after the participants were seated for 5 min using a digital automatic BP monitor (Dinamap model Pro 100V2, GE Medical Systems Information Technologies, Inc. (Milwaukee, WI, USA) in SiMES and Dinamap model Pro 100V2, Criticon, Norderstedt, Germany in SP2). If the BP measurements differed by more than 10 mm Hg systolic and 5 mm Hg diastolic, a third measurement was taken and the BP of the individual was taken as the average of the two closest readings. Hypertension was defined as systolic BP X140 mm Hg or diastolic BP X90 mm Hg or self-reported physician-diagnosed hypertension. For the current analysis, we excluded those with hypertension. Prehypertension was defined as systolic BP 120 --139 mm Hg or diastolic BP 80 --89 mm Hg based on the Seventh Report of the Joint National Committee (JNC 7) on Prevention, Detection, Evaluation and Treatment of High Blood Pressure recommendations. 13 
Measurement of exposure
Information on participants' demographic characteristics, lifestyle factors and medical history were obtained using a standardized questionnaire. Cigarette smoking was categorized into never, former and current smokers and alcohol consumption into ever drinkers and never drinkers irrespective of quantity. Body mass index (BMI) was calculated as weight in kilograms divided by the square of height in meters (kg m -2 ). Diabetes mellitus was defined as fasting plasma glucose X7 mmol l À1 (X126 mg dl
À1
) or selfreported physician-diagnosed diabetes or use of glucose-lowering medication in SP2, and as non-fasting plasma glucose X11.1 mmol l
(X200 mg dl À1 ) or self-reported physician-diagnosed diabetes or use of glucose-lowering medication in SiMES. CVD was defined as self-reported myocardial infarction, stroke or angina. High-sensitivity CRP was assayed on a Roche/Integra 400 Analyzer (Roche Diagnostics, Rotkreuz, Switzerland) by a particle-enhanced immunoturbidimetric method. The intra-and inter-assay precision were 0.6 --1.3% and 2.3 --3.1%, respectively. Serum lipids and CRP were measured from fasting blood samples in SP2 and from non-fasting blood samples in SiMES. All serum biochemistry tests were carried out at the National University Hospital Reference Laboratory.
Statistical analysis
Although in preliminary analyses the pattern of association between CRP and prehypertension was similar in the two study populations (P for interaction by study center ¼ 0.9), as the two cohorts differed significantly in the prevalence of risk factors and prehypertension, we presented all analyses separately for the two study cohorts. CRP levels were analyzed both as categorical and continuous variables. For the categorical analysis CRP levels were grouped into three categories: 27 o1, 1 --3 and 43 mg l
À1
and also as quartiles. For the continuous analysis CRP was log-transformed owing to its skewed distribution. The median (interquartile range) of CRP was 0.9 (1.8) in SP2 and 1.5 (2.5) mg l
. We compared the selected characteristics of the study population by race --ethnicity and by study cohort using analysis of variance or chi-square (w 2 ) tests as appropriate. We then examined the association between CRP and prehypertension in two logistic regression models: (1) age-and sex-adjusted model; (2) multivariable model, additionally adjusted for ethnicity (Chinese, Malay, Indian) in SP2, smoking status (never, former and current), alcohol consumption (absent or present), diabetes status (absent or present), BMI (kg m À2 ) and total cholesterol (mmol l À1 ). Tests for trend were performed by modeling CRP categories as an ordinal variable in the corresponding logistic regression models. To examine the consistency of the association between CRP categories and prehypertension, we performed subgroup analysis stratified by sex, race --ethnicity and BMI (o25, X25 kg m
À2
). Statistical interaction between CRP categories and each of the stratifying variables was examined in the corresponding logistic regression model by including cross-product interaction terms.
To examine the dose --response relationship of the observed association between serum CRP level and prehypertension without linearity assumptions, we used flexible nonparametric logistic regression employing the generalized additive modeling approach (R System for Statistical Computing, available from Comprehensive R Archive Network (http://www.CRAN.Rproject.org)) to calculate the odds of prehypertension, adjusting for all covariates in the multivariable model; the predicted odds of prehypertension were then plotted against increasing CRP levels (on the log scale).
We performed several supplementary analyses by repeating the multivariable model in Table 2 : (1) using quartiles of CRP (o0.4, 0.4 --1.0, 1.1 --2.6, 42.6 mg l À1 ), (2) after excluding participants with CRP levels suggestive of clinical inflammation (410 mg l À1 , n ¼ 100 in SP2 and n ¼ 44 in SiMES), (3) after excluding participants with a history of CVD (n ¼ 41 in SP2 and n ¼ 62 in SiMES) to study the impact of CVD on the observed positive association between CRP and prehypertension, (4) after excluding participants aged X60 years (n ¼ 202 in SP2 and n ¼ 180 in SiMES) to account for the impact of aging on both inflammation and hypertension, (5) additionally adjusting for statin use to account for the antiinflammatory effect of statin(n ¼ 146 in SP2 and 41 in SiMES) and (6) additionally adjusting for anti-hypertensive medication use (n ¼ 33 in SiMES and n ¼ 0 in SP2). Table 1 shows the characteristics of the study population by study cohort and ethnicity. Among the three ethnic groups, Malays in both the study cohorts were more likely to be former/current smokers, have higher levels of systolic BP and total cholesterol, and less likely to consume alcohol; Chinese were more likely to be younger, female, less likely to smoke, more likely to consume alcohol, have lower prevalence of diabetes and lower levels of systolic and diastolic BP, and total cholesterol levels; Indians had higher prevalence of diabetes. Table 2 shows the characteristics of the study cohorts by prehypertension status. The prevalence of prehypertension was 50.7% in SP2 cohort and 69.0% in SiMES cohort. In both SP2 and SiMES cohorts, compared with those without prehypertension, those with prehypertension were more likely to be older, have higher prevalence of diabetes and higher levels of systolic BP, diastolic BP, BMI, and total cholesterol. Further, in the SP2 cohort, those with prehypertension were less likely to be female, and more likely to be former/current smokers.
RESULTS
In univariate analysis, age, female, BMI, current smoking, alcohol consumption and diabetes were significantly associated with CRP in SP2; female and BMI were significantly associated with CRP in SiMES. We checked for multicollinearity among the variables by examining the variance inflation factor (VIF), considering a VIF value 42.5 as indicative of multicollinearity, following the recommendations by Allison. 28 Regression diagnostics revealed acceptable VIF values for the independent variables included in the multivariable model (VIF values ranged from 1.02 to 1.17 in SP2 and from 1.01 to 1.49 in SiMES), indicating the absence of multicollinearity. Table 3 shows the association between CRP levels and prehypertension in both the study cohorts. The prevalence of prehypertension increased with increasing categories of CRP in both the cohorts (P for trend o0.0001 in SP2 and 0.007 in SiMES). Compared with CRPo1 mg l Àl both CRP 1 --3, CRPX3 mg l À1 were significantly associated with prehypertension in both the age and sex-adjusted model and the multivariable model in both the cohorts. This positive association between CRP and prehypertension was also evident in analyses where CRP was analyzed as a continuous variable in both the cohorts. Table 4 shows the association between CRP levels and prehypertension in subgroups of gender, race --ethnicity (in SP2), BMI categories and diabetes status in both study cohorts. In the SP2 cohort, the association between CRP and prehypertension was consistently present in men and women (P-interaction by sex ¼ 0.1), Chinese, Malays and Indians (P-interaction by race --ethnicity ¼ 0.2) and among those with and without diabetes (P-interaction by diabetes ¼ 0.5). However, when stratified by BMI categories, the association was stronger among those with BMI o25 kg m À2 (P-interaction by BMI categories ¼ 0.03). In the SiMES cohort, the association between CRP and prehypertension was consistently present in subgroups of gender and BMI categories (P-interaction by sex ¼ 0.8 and P-interaction by BMI categories ¼ 0.5). However, when stratified by diabetes status, the association was stronger among those without diabetes (P-interaction by diabetes status ¼ 0.05). Figure 1 shows the dose --response relationship between serum CRP levels and prehypertension by employing nonparametric models without linearity assumptions. A continuous positive association was observed between log CRP and prehypertension in both SP2 (Figure 1a) and SiMES (Figure 1b) cohorts; however, the curve was steeper in the SiMES cohort.
We performed several supplementary analyses by repeating the multivariable model in Table 2 . First, using quartiles of CRP did not materially alter the results; in the SP2 cohort, compared with quartile 1 (referent) of CRP, the multivariable odds ratio (OR) (95% confidence interval (CI)) of prehypertension was 1. 
DISCUSSION
The current study, analyzing data from two independent population-based Asian cohorts, shows that elevated CRP levels are associated with prehypertension among subjects without hypertension. This association was found to be independent of age, sex, race --ethnicity, smoking status, alcohol consumption, diabetes, BMI and total cholesterol and was consistently present when CRP was analyzed either as a categorical or as a continuous variable. Further, this association was consistent across the two cohorts with different populations and was consistently present in men and women, and in Chinese, Malays and Indians. Adjusted for age (years), sex (male, female), race --ethnicity (Chinese, Malay, Indians) in SP2, body mass index (kg m À2 ), smoking status (never, former, current), ever drinker (absent, present), diabetes (absent, present) and total cholesterol (mmol l À1 ). Table 4 . Association between serum CRP and prehypertension within selected subgroups
Subgroups
CRP categories P-interaction ), smoking status (never, former, current), ever drinker (absent, present), diabetes (absent, present) and total cholesterol (mmol l
À1
).
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Our findings of these associations in Asians add weight to previous studies conducted in the Western populations. 10, 20, 21 In the third National Health and Nutrition Examination Survey (NHANES III) in the United States, both systolic and diastolic BP in the prehypertension range were significantly associated with elevated CRP. 20 In the ATTICA study in Europe, prehypertension was associated with elevated levels of CRP in men and women. 21 In the Women's Health Study in the United States, elevated CRP was associated with an increased risk of developing hypertension, including those with baseline BP in the prehypertension range. 10 Similar associations of other inflammatory markers, including tumor necrosis factor-alpha, amyloid-a, homocysteine, white blood cell counts and interleukin-6, with prehypertension 21 and hypertension have been reported. 29 Our findings are also consistent with previous studies that reported an association between CRP and hypertension. 8 --11,30,31 Several mechanisms have been postulated linking elevated levels of CRP with the development of prehypertension. Experimental studies have shown that elevated CRP stimulates endothelial dysfunction, leading to downregulation of nitric oxide production and vasoconstriction, 32 and may promote expression of angiotensin II type 1 receptor by vascular smooth muscle cells, leading to the development of hypertension. 33, 34 Another possible mechanism by which CRP increases BP could be by increasing large-artery stiffness, leading to adverse vascular effects involved in the pathogenesis of hypertension. 35 Clinical trials have shown that treatment with angiotensin-converting enzyme (ACE) inhibitor, a potent antihypertensive agent, reduces CRP concentrations in hypertensive patients. 36, 37 Also, elevated CRP is known to be related to insulin resistance, which in turn is associated with hypertension. 38 --42 We found that the association between CRP and prehypertension was stronger among those with BMI o25 kg m À2 in the SP2 cohort. However, the same was not observed in the SiMES cohort. Similarly, the association between CRP and prehypertension was stronger among those without diabetes in the SiMES cohort (P-interaction ¼ 0.05). Although a similar observation was observed in the SP2 cohort, there was no significant interaction by diabetes status (P-interaction ¼ 0.8).
The strengths of the current study include the availability of two large independent population-based samples with similar methodology and information on potential confounders. The consistency of our findings across the two populations, the multi-ethnic SP2 population and the homogeneous SiMES population, increases the validity of our study findings. Our study has some limitations. First, measurement of BP and CRP levels was based on a single occasion. This could have resulted in misclassification of both exposure and outcome. However, inaccuracy of measurement, if any, is nondifferential and is likely to underestimate the strength of association. Further, CRP has been shown to be less prone to fluctuations over time. 43 Second, it may be possible that our results are biased by residual confounding from unmeasured variables, for example, waist circumference and physical activity, which have been shown to be associated with both hypertension and inflammation. We also did not have information on infectious and autoimmune diseases, malignancies, and recent trauma or surgery. Failure to exclude these patients from the analysis may have potentially biased our results. Third, the cross-sectional nature of the study precludes the understanding of the temporal relationship between elevated levels of CRP and prehypertension.
In conclusion, data from two large population-based Asian cohorts show that elevated CRP levels are associated with prehypertension among subjects free of hypertension. As prehypertension is a stage in the high-BP continuum where hypertension prevention efforts have been shown to be effective, 13 future randomized intervention trials should clarify if lowering CRP levels in this stage can prevent or delay the onset of hypertension in the general population.
What is known about this topic
Prehypertension is an earlier stage in the continuum of hypertension where prevention efforts are effective in delaying or preventing the onset of hypertension. Studies conducted among Western populations have shown an association between C-reactive protein, a marker of inflammation, and prehypertension.
No previous study has examined this association in Asian populations.
What this study adds
The current study, analyzing data from two independent populationbased Asian cohorts, confirms that elevated CRP levels are associated with prehypertension. This association was consistent across subgroups of gender and race --ethnicity. ) in SP2 (a) and SiMES (b) populations. The black line represents the predicted odds of prehypertension from nonparametric logistic regression; the dashed lines represent 95% confidence limits for the nonparametric logistic regression estimates. The nonparametric logistic regression was adjusted for age (years), sex (male, female), race --ethnicity (Chinese, Malay, Indians) in SP2, body mass index (kg m À2 ), current smoker (absent, present), ever drinker (absent, present), diabetes (absent, present) and total cholesterol (mmol l À1 ).
C-reactive protein and prehypertension C Sabanayagam et al
